Toxys, a biotechnology company specialising in innovative in vitro toxicology solutions, and Charles River Laboratories&...
Germany-based Fresenius SE & Co. KGaA has entered an exclusive development agreement with China's WuXi Biologics, a ...
On 8 October 2026, a number quietly crossed a line. According to data provider PharmCube, the value of overseas licensin...
Thermo Fisher Scientific, the world leader in serving science, introduces the Thermo Scientific AmpSure Universal SYBR G...
As autoimmune and allergic diseases present increasingly complex diagnostic challenges, laboratories face growing pressu...
Merck, a leading science and technology company, has signed a definitive agreement to divest its contract deve...
WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), tod...
Samsung Biologics reported third-quarter revenue of KRW 1.49 trillion and operating profit of KRW 640 billion, supported...
QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an off...
South Korea-based Samsung Bioepis has announced a landmark 10-year agreement with its local partners in Brazil—sta...
Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As a...
Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...
Forty years on, a different question When BioJapan opened its doors for the first time in 1986, Japan's pharmaceutical ...
As pharmaceutical innovation accelerates, mature medicines remain essential to healthcare systems, y...
Everest Medicines announced on June 26, 2026, that China’s National Medical Products Administration (NMPA) accepte...
Charles River Laboratories International, Inc. and Autolomous announced the launch of Apollo Orchestrate on October 6, 2...
Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organisations, has announced the...
Sartorius and France-based MAbSilico have entered a non-exclusive collaboration combining AI-powered predict...
Aptar Pharma, a global leader in drug delivery, dosing and protection technologies and services, has announced a new res...
As Asia-Pacific’s manufacturing landscape becomes more sophisticated, purification and separation technolo...
Denmark-based Lundbeck has received marketing authorisation from Japan’s Ministry of Health, Labour and Welfare fo...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
China Medical System Holdings has announced that initial prescriptions for Silevimig Injection have been issued at multi...
Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
